SCHMIDT, A.F, SWERDLOW, D.I, HOLMES, M.V, PATEL, R.S, FAIRHURST-HUNTER, Z, LYALL, D.M, HARTWIG, F.P, HORTA, B.L, HYPPÖNEN, E, POWER, C, MOLDOVAN, M, VAN IPEREN, E, HOVINGH, G.K, DEMUTH, I, NORMAN, K, STEINHAGEN-THIESSEN, E, DEMUTH, J, BERTRAM, L, LIU, T, COASSIN, S, WILLEIT, J, KIECHL,S, WILLEIT, K, MASON, D, WRIGHT, J, MORRIS, R, WANAMETHEE, G, WHINCUP, P, BEN-SHLOMO, Y, MCLACHLAN, S, PRICE, J.F, KIVIMAKI, M, WELCH, C, SANCHEZ-GALVEZ, A, MARQUES-VIDAL, P, NICOLAIDES, A, PANAYIOTOU, A.G, ONLAND-MORET, N.C, VAN DER SCHOUW, Y.T, MATULLO, G, FIORITO, G, GUARRERA, S, SACERDOTE, C, WAREHAM, N.J, LANGENBERG, C, SCOTT, R, LUAN, J, BOBAK, M, MALYUTINA, S, PAJAK, A, KUBINOVA, R, TAMOSIUNAS, A, PIKHART, H, HUSEMOEN, L.L, GRARUP, N, PEDERSEN, O, HANSEN, T, LINNEBERG, A, SIMONSEN, K.S, COOPER, J, HUMPHRIES, S.E, BRILLIANT, M, KITCHNER, T, HAKONARSON, H, CARRELL, D.S, MCCARTY, C.A, KIRCHNER, H.L, LARSON, E.B, CROSSLIN, D.R, DE ANDRADE, M, RODEN, D.M, DENNY, J.C, CARTY, C, HANCOCK, S, ATTIA, J, HOLLIDAY, E, DONNELL, M.O, YUSUF, S, CHONG, M, PARE, G, VAN DER HARST, P, SAID, M.A, EPPINGA, R.N, VERWEIJ, N, SNIEDER, H, LIFELINES COHORT STUDY GROUP, CHRISTEN, T, MOOK-KANAMORI, D.O, GUSTAFSSON, S, LIND, L, INGELSSON, E, PAZOKI, R, FRANCO, O, HOFMAN, A, UITTERLINDEN, A, DEHGHAN, A, TEUMER, A, BAUMEISTER, S, DÖRR, M, LERCH, M.M, VÖLKER, U, VÖLZKE, H, WARD, J, PELL, J.P, SMITH, D.J, MEADE, T, MAITLAND-VAN DER ZEE, A.H, BARANOVA, E.V, YOUNG, R, FORD, I, CAMPBELL, A, PADMANABHAN, S, BOTS, M.L, GROBBEE, D.E, FROGUEL, P, THUILLIER, D, BALKAU, B, BONNEFOND, A, CARIOU, B, SMART, M, BAO, Y, KUMARI, M, MAHAJAN, A, RIDKER, P.M, CHASMAN, D.I, REINER, A.P, LANGE, L.A, RITCHIE, M.D, ASSELBERGS, F.W, CASAS, J.P, KEATING, B.J, PREISS, D, HINGORANI, A.D, UCLEB CONSORTIUM and SATTAR, N.
(2017)
PCSK9 genetic variants and risk of type 2 diabetes: a Mendelian randomisation study.
Lancet Diabetes & Endocrinology, 5(2), 97-105.